 |
BioWorld-Insight-2003-04-28
Stock Winners and Losers For The Week
Biotech - Biotech Collaborations: Modified And Terminated Agreements, Feb. 20 - April 23, 2003
No Abstract
Psoriasis Survey Finds Market Robust, Room For Many Winners
Familiarity may breed contempt in some settings, but in the prescription world it often means a leg up on competing drugs. Such appears to be the case with Enbrel (etanercept), Amgen Inc.'s rheumatoid arthritis treatment approved in 1998.